Influence of Episodes of Intermittent Viremia (“Blips”) on Immune Responses and Viral Load Rebound in Successfully Treated HIV-Infected Patients-Reference-Cited by-同舟云学术

Influence of Episodes of Intermittent Viremia (“Blips”) on Immune Responses and Viral Load Rebound in Successfully Treated HIV-Infected Patients

Published:2013-01 Issue:1 Volume:29 Page:68-76
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Castro Pedro¹,Plana Montserrat²,González Raquel³⁴,López Anna²,Vilella Anna³⁴,Nicolas Jose M.¹,Gallart Teresa²⁵,Pumarola Tomàs⁶,Bayas José M.³,Gatell José M.⁷,García Felipe⁷

Affiliation:

1. Medical Intensive Care Unit, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

2. Retrovirology and Viral Immunopathology Laboratories, HIVACAT (HIV Vaccine Development in Catalonia), Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

3. Preventive Medicine Department Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

4. Barcelona Centre for International Health Research (CRESIB), Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

5. Immunology Laboratory, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

6. Microbiology Laboratory, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

7. Infectious Diseases Unit, HIVACAT (HIV Vaccine Development in Catalonia), Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2012.0145

Reference46 articles.

1. Prevalence and Predictive Value of Intermittent Viremia With Combination HIV Therapy

2. Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients

3. Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantification

4. Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influencing factors and adverse outcomes of virologic rebound states in anti-retroviral-treated individuals with HIV infection;Journal of Virus Eradication;2023-03

2. Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio;Journal of the Pediatric Infectious Diseases Society;2023-02-02

3. Predictors of low‐level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort;HIV Medicine;2022-03

4. Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression;AIDS Research and Human Retroviruses;2019-06

5. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure;Clinical Infectious Diseases;2019-02-16